BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19702241)

  • 1. Evaluation of virtual screening as a tool for chemical genetic applications.
    Campagna-Slater V; Schapira M
    J Chem Inf Model; 2009 Sep; 49(9):2082-91. PubMed ID: 19702241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
    Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
    J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
    Park H; Bhattarai BR; Ham SW; Cho H
    Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening - what does it give us?
    Köppen H
    Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient hit-finding approaches for histone methyltransferases: the key parameters.
    Ahrens T; Bergner A; Sheppard D; Hafenbradl D
    J Biomol Screen; 2012 Jan; 17(1):85-98. PubMed ID: 21990582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
    J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
    J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
    Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
    J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P; Saxena AK
    J Chem Inf Model; 2006; 46(1):39-51. PubMed ID: 16426038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
    Kuck D; Singh N; Lyko F; Medina-Franco JL
    Bioorg Med Chem; 2010 Jan; 18(2):822-9. PubMed ID: 20006515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput virtual screening of proteins using GRID molecular interaction fields.
    Sciabola S; Stanton RV; Mills JE; Flocco MM; Baroni M; Cruciani G; Perruccio F; Mason JS
    J Chem Inf Model; 2010 Jan; 50(1):155-69. PubMed ID: 19919042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eHiTS-to-VMD interface application. The search for tyrosine-tRNA ligase inhibitors.
    Eitner K; Gaweda T; Hoffmann M; Jura M; Rychlewski L; Barciszewski J
    J Chem Inf Model; 2007; 47(2):695-702. PubMed ID: 17381179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase.
    Luzhkov VB; Selisko B; Nordqvist A; Peyrane F; Decroly E; Alvarez K; Karlen A; Canard B; Qvist J
    Bioorg Med Chem; 2007 Dec; 15(24):7795-802. PubMed ID: 17888664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustering and classifying diverse HIV entry inhibitors using a novel consensus shape-based virtual screening approach: further evidence for multiple binding sites within the CCR5 extracellular pocket.
    Pérez-Nueno VI; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Nov; 48(11):2146-65. PubMed ID: 18942828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. StructRank: a new approach for ligand-based virtual screening.
    Rathke F; Hansen K; Brefeld U; Müller KR
    J Chem Inf Model; 2011 Jan; 51(1):83-92. PubMed ID: 21166393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening of Abl inhibitors from large compound libraries by support vector machines.
    Liu XH; Ma XH; Tan CY; Jiang YY; Go ML; Low BC; Chen YZ
    J Chem Inf Model; 2009 Sep; 49(9):2101-10. PubMed ID: 19689138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.